| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |